Invesco Biotechnology & Genome ETF (PBE) Holdings List

$92.04 0.00 (0.00%)

As of 07/2/2026 04:10 PM Eastern

What stocks does PBE hold?

The Invesco Biotechnology & Genome ETF (PBE) top stock holdings include Vertex Pharmaceuticals, Amgen, and Biogen. The top 25 PBE holdings ordered by weight make up 86.94% of the total fund. PBE is an equity fund in the sector category that invests in publicly traded companies, focused on health care strategies within the North America region. This page includes a complete PBE stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.

Top 25 PBE Holdings

Rank	Company	Current Price	Weight	Shares Held
1	VRTX Vertex Pharmaceuticals	$528.04	5.04%	28,896
2	AMGN Amgen	$374.15	4.81%	37,497
3	BIIB Biogen	$216.12	4.79%	65,241
4	RPRX Royalty Pharma	$57.77	4.65%	233,880
5	ALNY Alnylam Pharmaceuticals	$312.78	4.54%	42,629
6	REGN Regeneron Pharmaceuticals	$654.27	4.47%	19,849
7	UTHR United Therapeutics	$555.91	4.30%	21,777
8	GILD Gilead Sciences	$131.27	4.24%	94,196
9	TECH Bio-Techne	$70.83	3.68%	143,235
10	VCYT Veracyte	$57.08	3.31%	155,417
Get the Latest News and Ratings for PBE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter.
11	CDNA CareDx	$29.19	3.23%	318,987
12	RGEN Repligen	$142.40	3.15%	59,649
13	PTCT PTC Therapeutics	$83.31	3.12%	101,567
14	VCEL Vericel	$46.98	3.06%	196,482
15	PTGX Protagonist Therapeutics	$131.62	3.06%	68,723
16	ILMN Illumina	$188.68	3.05%	47,313
17	BCRX BioCryst Pharmaceuticals	$9.84	2.92%	811,213
18	ACAD ACADIA Pharmaceuticals	$25.97	2.79%	323,188
19	INCY Incyte	$116.86	2.77%	70,762
20	QGEN Qiagen	$40.08 -0.1%	2.74%	193,331
21	BMRN BioMarin Pharmaceutical	$58.99	2.71%	129,935
22	EXEL Exelixis	$55.85	2.66%	137,474
23	HALO Halozyme Therapeutics	$79.45	2.64%	99,985
24	NBIX Neurocrine Biosciences	$174.26	2.63%	44,121
25	ANAB AnaptysBio	$63.42	2.58%	118,937

PBE Geographic Exposure

PBE's largest geographic exposure is United States at 97.3%, followed by Netherlands at 2.7%.

United States
97.3%
Netherlands
2.7%

PBE Currency Exposure

PBE is exclusively exposed to USD.

USD
94.8%

PBE Sector Exposure

PBE's largest sector exposure is Health Care at 97.3%.

Health Care
97.3%

PBE Industry Exposure

PBE's largest industry exposure is Biotechnology at 80.6%, followed by Health Care Equipment & Supplies at 16.7%.

Biotechnology
80.6%
Health Care Equipment & Supplies
16.7%

PBE Sub-Industry Exposure

PBE's largest sub-industry exposure is Biotechnology at 80.6%, followed by Life Sciences Tools & Services at 13.3%.

Biotechnology
80.6%
Life Sciences Tools & Services
13.3%
Health Care Equipment
3.4%

Related Companies and Tools

Related Companies

This page (NYSEARCA:PBE) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Invesco Biotechnology & Genome ETF (PBE) Holdings List